Does ALPELISIB Cause Disease progression? 197 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 197 reports of Disease progression have been filed in association with ALPELISIB (PIQRAY). This represents 2.3% of all adverse event reports for ALPELISIB.
197
Reports of Disease progression with ALPELISIB
2.3%
of all ALPELISIB reports
38
Deaths
9
Hospitalizations
How Dangerous Is Disease progression From ALPELISIB?
Of the 197 reports, 38 (19.3%) resulted in death, 9 (4.6%) required hospitalization, and 8 (4.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPELISIB. However, 197 reports have been filed with the FAERS database.
What Other Side Effects Does ALPELISIB Cause?
Hyperglycaemia (1,575)
Rash (1,393)
Diarrhoea (1,336)
Blood glucose increased (1,105)
Death (921)
Nausea (860)
Fatigue (817)
Decreased appetite (546)
Weight decreased (508)
Malignant neoplasm progression (497)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ALPELISIB Alternatives Have Lower Disease progression Risk?
ALPELISIB vs ALPHA.-LIPOIC ACID
ALPELISIB vs ALPHA.-TOCOPHEROL
ALPELISIB vs ALPHA.-TOCOPHEROL, D-
ALPELISIB vs ALPHA.-TOCOPHEROL, DL-
ALPELISIB vs ALPHA.1-PROTEINASE INHIBITOR HUMAN